Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Ovarian Cancer
  •  Colon Cancer
  •  Radiological Techniques and Scans
  •  Lung Cancers
  •  Colorectal Cancer
  •  Hormone Therapy
  •  Surgical Oncology
  •  Chemotherapy and Radiotherapy


Citation: Clin Oncol. 2022;7(1):1888.DOI: 10.25107/2474-1663.1888

Bevacizumab Monotherapy for Metastatic Renal Cell Carcinoma in a Pediatric Patient

Hadelle Habitzreuter Hassmann, Ana Paula Kuczynski Pedro Bom and Lucas Henrique de Almeida Silva

Department of Pediatric Oncology, Little Prince Hospital, Brazil

*Correspondance to: [email protected] 

 PDF  Full Text Case Report | Open Access


Renal cell carcinoma rarely occurs in children and adolescents. Localized disease has good prognosis, whereas distant metastasis have poor prognosis, with no effective therapy. Recently, 10% to 20% of adult patients have shown an apparent response to immunotherapy; however the limited pediatric experience confirms a very poor prognosis. We present a case from a patient with renal cell carcinoma with liver metastasis who has been treating with bevacizumab for ten years. She is doing well, without side effects, presenting reduction in size and number of the liver nodules.


Cite the Article:

Hassmann HH, Pedro Bom APK, de Almeida Silva LH. Bevacizumab Monotherapy for Metastatic Renal Cell Carcinoma in a Pediatric Patient. Clin Oncol. 2022;7:1888..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Characteristics of Adult Glioblastoma in Kuwait
 Abstract  PDF  Full Text
Application of First-Line Steady-State Mobilization vs. Conventional Chemotherapy Mobilization for Peripheral Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients
 Abstract  PDF  Full Text
View More...